Products for Research Use Only
RegisterLogin

ZZM-1220

CAT: 0804-HY-156285-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-156285-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ZZM-1220 is a histone lysine methyltransferase G9a/GLP covalent inhibitor with IC50s of of 458 nM and 924 nM, respectively. ZZM-1220 inhibits H3K9me2 in cells and significantly induces apoptosis of triple-negative breast cancer (TNBC) cells and blocks the cell cycle in the G2/M phase[1].
UNSPSC
12352005
Target
Apoptosis; Histone Methyltransferase
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zzm-1220.html
Purity
98.74
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C=CC(NC1=CC(C2=NC3=CC(OC)=C(C=C3C(NC4CCN(CC4)C)=N2)OC)=CC=C1)=O
Molecular Formula
C25H29N5O3
Molecular Weight
447.53
References & Citations
[1]Qiangsheng Zhang, et al. Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer. Eur J Med Chem. 2023 Sep 28:261:115841.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EHMT1/GLP/KMT1D; EHMT2/G9a/KMT1C

Related Products

CatalogName
HY-14404MK-1220
HY-149628HM-1228
HY-162753-01ZW-1226
HY-179396T-1228
HY-15115SUAM 1221
HY-106304ME-1228
HY-153386-01CPD-1224
HY-107186EO-122
HY-119136BFF-122
HY-167856-01RTI-122

Alternative Products

CatalogName
T79776-01ZZM-1220
MBS3603898-01KY-1220
MBS5779559-01AM-1220
sc-361259AMRS 1220
MBS3840231-01AM 1220
GTR19212468-01MK-1220
A14171-50AM 1220 50mg
A14171-100AM 1220 100mg
TUB1404Trident Screwcap for TUB1208/1210/1220
APR03241GPolyclonal CLASP1 Antibody (aa1171-1220)

Popular Products